Protein Expression Market to Hit USD 4.82 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™
The global protein expression market is expected to reach USD 4.82 billion in 2029 from USD 3.41 billion in 2024 at a CAGR of ...
PR Newswire1d
Genomics Market to Hit USD 66.85 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™
The product segment accounted for the largest share of the genomics market in 2023. This dominance is primarily attributable to the reagents, kits, and other consumables used in sequencing, PCR, and ...
Business Wire3d
European Life Science Tools and Reagents Market Research 2023-2024 & 2029: Thermo Fisher Scientific, Danaher., Merck, Qiagen and Roche Lead the Industry - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering. The European market for life science tools and reagents and ...
Future Market Insights8d
Fungal Staining Reagent Market to Reach USD 5.0 Billion by 2033, Driven by Increasing Organ Transplants and Rising Immunocompromised Population | FMI
Future Market Insights (FMI) has released a comprehensive analysis on the global fungal staining reagent market, revealing a promising growth trajectory. The market is estimated to be valued at USD ...
PharmiWeb8d
Global Antioxidant Reagents Market Expected to Surpass USD 5,543.5 million by 2034, Driven by Expanding R&D in Biotechnology and Healthcare | FMI
The global antioxidants reagents market is poised for significant growth, with projected sales reaching USD 5,543.5 million by 2034, up from an estimated USD 2,615.8 million in 2024. According to the ...
C&EN17d
How do endotoxin tests work?
Decades ago, scientists looking for an alternative to animal testing cloned factor C, the horseshoe crab protein that senses ...
Seeking Alpha20d
Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat
Merck & Co., Inc.'s Q3 earnings report is anticipated on 31st October — next Thursday. Despite strong Q2 performance, Merck's stock fell due to a guidance downgrade related to issues with key ...
FiercePharma20d
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...
Outsourcing-pharma21d
Merck acquires cancer startup in a deal worth up to $1.3 billion
Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair processes. Modifi Biosciences, a spin out of Yale University founded in 2021, ...